Endometrial intraepithelial neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 world health organization classification for endometrial hyperplasia

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 10, 2013, Pages 5935-5939

  Li, Xiao Chao ^a   Song, Wen Jing ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Beta catenin; Endometrial hyperplasia; Endometrial intraepithelial neoplasia; World health organization

Indexed keywords

BETA CATENIN; TUMOR MARKER;

ARTICLE; CANCER STAGING; CARCINOMA IN SITU; CLASSIFICATION; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; HYPERPLASIA; METABOLISM; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; WORLD HEALTH ORGANIZATION;

BETA CATENIN; CARCINOMA IN SITU; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 84890503121     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.10.5935     Document Type: Article

References (24)

1. Baak JP, Mutter GL (2005). EIN and WHO94. J Clin Pathol, 58, 1-6.
2. Bergeron C, Nogales FF, Masseroli M, et al (1999). A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol, 23, 1102-8.
3. Doll A, Abal M, Rigau M, et al (2008). Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol, 108, 221-9.
4. Duan GJ, Yan XC, Bian XW, et al (2004). The significance of β-catenin and matrix metalloproteinase-7 expression in colorectal adenoma and carcinoma. Chin J Pathol, 33, 518-22. (in Chinese)
5. Francz M (2008). The premalignant disease of the endometrium: endometrial intraepithelial neoplasia. Magy Onkol, 52, 35-40. (in Hungarian)
6. Gültekin M, Diribas K, Dursun P, Ayhan A (2009). Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN). Eur J Gynaecol Oncol, 30, 396-401.
7. Horn LC, Meinel A, Handzel R, Einenkel J (2007). Histopathology of endometrial hyperplasia and endometrial carcinoma: an update. Ann Diagn Pathol, 11, 297-311.
8. Jeong JW, Lee HS, Franco HL, et al (2009). beta-catenin mediates glandular formation and dysregulation of betacatenin induces hyperplasia formation in the murine uterus. Oncogene, 28, 31-40.
9. Kendall BS, Ronnett BM, Isacson C, et al (1998). Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol, 22, 1012-9.
10. Kurman RJ, Kaminski PF, Norris HJ (1985). The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer, 56, 403-12.
11. Li YJ, Ji XR (2003). Relationship between the expression of β-cat, cyclin D1 and c-myc and the occurrence and biological behavior of pancreatic cancer. Chin J Pathol, 32, 223-41. (in Chinese)
12. Moreno-Bueno G, Hardisson D, Sarrio D, et al (2003). Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol, 199, 471-8.
13. Mutter GL, Baak JP, Crum CP, et al (2000a). Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol, 190, 462-9.
14. Mutter GL, Lin MC, Fitzgerald JT, et al (2000b). Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst, 92, 924-30.
15. Mutter GL, Zaino RJ, Baak JP, et al (2007). Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol, 26, 103-14.
16. Norimatsu Y, Moriya T, Kobayashi TK, et al (2007). Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women. Ann Diagn Pathol, 11, 103-8.
17. Park BH, Vogelstein B, Kinzler KW (2001). Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci U S A, 98, 2598-603.
18. Pavlakis K, Messini I, Vrekoussis T, et al (2010). PTEN-loss and nuclear atypia of EIN in endometrial biopsies can predict the existence of a concurrent endometrial carcinoma. Gynecol Oncol, 119, 516-9.
19. Salman MC, Usubutun A, Boynukalin K, Yuce K (2010). Comparison of WHO and endometrial intraepithelial neoplasia classifications in predicting the presence of coexistent malignancy in endometrial hyperplasia. J Gynecol Oncol, 21, 97-101.
20. Shun CT, Wu MS, Lin MT, et al (2001). Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and Helicobacter pylori infection. Oncology, 60, 339-45.
21. Tavassoéli FA, Devilee P (2003). Pathology and Genetics Tumours of the Breast and Female Genital Organs. IARC Press, Lyon. pp 221-232.
22. Wong CM, Fan ST, Ng IO (2001). beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer, 92, 136-45.
23. Yang YF, Liao YY, Peng NF, et al (2012). Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Pathol Res Pract, 208, 708-12.
24. Zhou JJ, Luo Q, Yan W (2008). Endometrial intraepithelial neoplasia: a clinicopathologic analysis of 53 cases. Chin J Diag Pathol, 15, 438-40. (in Chinese)